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E-mail address: tatibana@bioa.eng.osaka-cu.ac.jp (Many miRNA inhibitors have been developed and they are chemically modiﬁed oligonucleotides
such as 20-O-methylated RNA and locked nucleic acid (LNA). Unmodiﬁed DNA was not yet reported
as a miRNA inhibitor because of the low afﬁnity of DNA/miRNA compared to mRNA/miRNA. We
designed a structured unmodiﬁed DNA that signiﬁcantly inhibits miRNA function. The clue struc-
ture for activity is the miRNA binding site between double stranded regions which is responsible
for the miRNA inhibitory activity and tight binding to miRNA. We developed the miRNA inhibitor
constructed with unmodiﬁed DNA, and named it LidNA, DNA that puts a lid on miRNA function.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction 20-O-methylated reverse complements of the mature miRNAmiRNAs are a class of endogenously expressed small regulatory
non-coding RNAs thought to negatively regulate target mRNAs by
binding with imperfect complementarity in their 30-untranslated
regions (30-UTR) [1,2]. The diverse nature ofmiRNA target sites is re-
ﬂected in the results of both experimentally validated and compu-
tationally based mirna target site predictions, which suggest that,
on average, each miRNA targets hundreds of genes [3,4]. miRNAs
have been demonstrated to play roles in cell differentiation and pro-
liferation. The transfection of miR-302s expression vector to cells,
without the other protein expression vector, led to the reprogram-
ing of human hair follicle cells into a human embryonic stem cell-
like pluripotent state [5,6]. Some miRNAs show differential expres-
sion levels in cancer and are able to affect cellular transformation,
carcinogenesis and metastasis, acting either as oncogenes or tumor
suppressors [7]. MiR-21, for example, is an unique miRNA in that it
is overexpressed inmost tumor types analysed so far. Moreover, the
overexpression of miR-21 was reported that leads to a pre-B malig-
nant lympolid-like phenotype, demonstrating that mir-21 is a gen-
uine oncogene [8].
Current biochemically based tools for the sequence-speciﬁc
inhibition of miRNA function are limited to single-stranded oligo-
nucleotide-based miRNA inhibitors. These molecules are fullychemical Societies. Published by E
anslated region; LNA, locked
A. Tachibana).sequences [9–12] and are believed to act as non-cleavable sub-
strates (antisense) of the RNA-induced silencing complex (RISC).
The miRNA inhibitory effects of alternative chemical modiﬁcation
patterns including locked nucleic acids (LNA), phosphorothioate
and 20-methoxyethyl modiﬁcations, have also been investigated
[13–15]. DNA vectors that express ‘microRNA sponge’ and ‘tough
decoy RNA’ as the competitive inhibitor of miRNA have been
described [16,17]. These expressed RNAs have mismatched
sequences in the central region of the miRNA target sequence,
and therefore, act as non-cleavable substrates of RISC. All above-
mentioned inhibitors of miRNA function presumably anneale to
the mature miRNA guide strand after RISC removes the passenger
strand. Chemically modiﬁed oligonucleotides such as LNA and
20-O-methylated RNA bind RNA with high afﬁnity compared to
RNA/RNA and RNA/DNA duplexes [17]. Moreover, RNA/RNA
duplexes have higher Tm values than RNA/DNA duplexes, hence,
in a previous study, antisense DNA did not inhibit miRNA function
[9]. In this article, we reported the ﬁrst effective unmodiﬁed DNA
based miRNA inhibitor and showed high afﬁnity miRNA binding
to miRNA binding sites between two double-stranded regions.2. Materials and methods
2.1. Reporter gene assay
The LidNA was constructed by the heating and slow cooling of
the mixture of the component oligonucleotides in PBS() buffer.lsevier B.V. All rights reserved.
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phoresis. The inhibitory activity of LidNA was measured by repor-
ter gene assay using pDsRed2-miR16 target containing three
miR-16 target sequences at 30-UTR of DsRed2 gene, using
pCAGGS-GFP as the control (Fig. 1B). The HEK293T cells were
seeded into 24-well plate (60000 cells/well). At day 1, cells were
transfected with the reporter and control vectors (50 ng each)
and 25 nM LidNA using Lipofectamine LTX (Invitrogen) according
to the manufacturer’s instructions. After two days, the cells were
harvested and disrupted with TBS containing 0.05% of Triton-
X100. The mixture was centrifuged and the ﬂuorescence of the
supernatant was measured with a ﬂuorescence microplate reader
(Thermo Scientiﬁc). The inhibitory activity of LidNA was expressed
as normalized DsRed2/GFP ratio relative to the control.
2.2. Binding assay of LidNA-type probe to miRNA
The binding assay of LidNA-type probe tomiRNAwasperformedon a
Biacore 3000 system (GEHealthcare). On the sensor chip CM5, streptavi-
din was immobilized and then 50 biotin-labeled anchor oligonucleotide,
50-tttttttttcaatacgactcactatagggc-30, was immobilized according to the
manufacturer’s instructions. LidNA-type, semi-LidNA-type, and single
strand probes were injected and annealed with anchor oligonucleotide.
The sequences of the probes were as follows: LidNA-type probe, 50-
ctggccggaacggccagCGCCAATATTTACGTGC TGCTAgccctatagtgagtcgtatta
cggatcccg-30, semi-LidNA-type probe, 50-cggccagCGCCAATATTTACGT
GCTGCTAgccctatagtgagtcgtattacggatcccg-30, single strand probe, 50-cggc
cagCGCCAATATTTACGTGCTGCTAttttttttttgccctatagtgagtcgtattacgga tccc
g-30. Upper case letters indicate themiR-16 binding sites, and the under-0.0 
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Fig. 1. The structure and activity of LidNA. (A) LidNA-16 (12) has two miR-16
binding sites between two double stranded regions. (B) Reporter gene assay using
pDsRed2-miR-16 target containing three miR-16 target sequences at 30-UTR of
DsRed2 gene and pCAGGS-GFP as the control of transfection efﬁciency. (C) LidNA
speciﬁcally inhibited miRNA activity by dose dependent manner. LidNA-143 and
ssLidNA-16 were not effective on miR-16 activity. Using LidNA-143 at 25 nM as the
standard, LidNA activity was expressed as normalized DsRed2/GFP ﬂuorescence
ratio. The sequences and structures of LidNAs and miR-16 are shown in Supple-
mentary information.line indicates the double-stranded regions. Using the prepared sensor
chip, miR-16 at appropriate concentration in PBS() buffer was injected
into the Biacore system and the sensorgram was obtained as shown in
Fig. 3. Kinetic propertieswere calculated according to themanufacturer’s
instructions.3. Results and discussion
3.1. Design of miRNA inhibitor with DNA
The binding ability of structured molecules such as antibodies is
generally believed to be higher than that of unstructured mole-
cules such as free peptides, and simple, complementary and sin-
gle-stranded DNA do not inhibit miRNA activity [9]. Hence,
structured DNA is also expected to have higher afﬁnity for miRNA
bound to RISC. We designed LidNA-16 as an miR-16 inhibitor, with
two miR-16 binding sites between two double-stranded regions
(Fig. 1A) that repress the free motion of the miRNA binding site.
Mismatch of inhibitor and miRNA in RISC is most effective in the
centre of the miRNA binding site [17–19]. Hence, three LidNA ana-
logues were constructed in which the miRNA binding site was
intercepted with a 4 nt random sequence at the 12th, 4th and
18th positions from the 50 end of the miRNA binding site [LidNA-
16(12), LidNA-16(4) and LidNA-16(18), respectively].
Reporter gene assay for miRNA inhibitory activity was per-
formed using pDsRed2-miR-16 target vector with three entirely
complementary sequences of miR-16 downstream of DsRed2 gene
stop codon and pCAGGS-GFP vector as the control (Fig. 1B). Inhib-
itor activity was expressed as normalized ratio of DsRed2 to GFP
ﬂuorescence. The LidNA-16(12) was an effective inhibitor of miR-
16 function in several cell lines, of which HEK293T, HepG2, and
MCF7 are known to produce miR-16 (Fig. 1C). Consistent with pre-
vious studies, LidNA-16(4) and LidNA-16(18) were less effective,
suggesting that LidNA-16(12) mediates inhibition of the miR-16
on RISC, and not to free miR-16. Because LidNA-16(12) was, there-
fore, used as the standard (hereafter ‘LidNA-16’).
LidNA-143 did not inhibit miR-16 function, indicating that Lid-
NA-16 is a sequence-speciﬁc inhibitor (Fig. 1C). LidNA-143 specif-
ically inhibited the function of exogenous miR-143 in HEK293T
cells, little producer of miR-143 (Fig. S1). Compared with LidNA-
143, the addition of LidNA-16 inhibited miR-16, 4.9-, 4.7- and
3.2-times more effectively in HEK293T, HepG2 and MCF7 cells,
respectively. These values are some superior to those achived using
other miRNA inhibitors, LNA and 20-O-methylated RNA, in the
same cells (Fig. S2). In dose experiments, LidNA-16 showed inhib-
itory activity over 10 nM, while LidNA-143 did not inhibit at 25 nM
(Fig. 1C). Surprisingly, single-stranded LidNA-16 (miRNA binding
site between two ssDNA strands) showed no effect at 50 nM. The
inhibition effect of LidNA-16 was sustained at least at 5 days and
LidNA-16 was detectable in cells at day 5 (Fig. S3). Details are un-
der investigation.3.2. Determination of the structural components necessary for the
inhibitory activity of LidNA
To determine the structural components necessary for the
inhibitory activity of LidNA, we designed the structural variations
of LidNA as shown in Fig. 2. Variations 2 and 3 are constructed
with structure 1 (LidNA-16) using an additional annealed strand
to keep LidNA open on one side that is annealed with one strand
of right or left double strand region and get LidNA to open the
one side. Due to higher mobility of miRNA binding site the
opened LidNAs, 2 and 3, were not expected to demonstrate
miR-16 inhibitory effects. The effects of opened LidNAs were low-
er but remained signiﬁcant. Structure variations 4 and 5 have a
A. Tachibana et al. / FEBS Letters 586 (2012) 1529–1532 1531single miR-16 binding site and an miR-21 or miR-302b binding
site, respectively. These variations also showed moderate effects,
indicating that two miRNA binding sites of LidNA were not neces-
sary for miRNA inhibition. In addition, variations 3, 4 and 5
showed same level of effects, indicating two miRNA binding sites
were not important for higher inhibitory effects. Variation 2
showed higher effect than variation 3, therefore, the inhibitory ef-
fects may be affected by the sequences of the insertion of miRNA
binding sites and double-stranded regions because the two0
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Fig. 2. The activities and the structures of LidNA-16 (1) and the structure variationsmiRNA binding sites have different sequences of the insertion
and the ﬂanking regions. Variations 6 to 11 possess a single
miRNA binding site between one or two double-stranded regions
at the 50 and 30 terminals. In comparison to variations 6, 7 and 8,
the variation 7 has a double-stranded region at its 50-terminal and
less effective than the variation 8 that has two double-stranded
regions at both the terminals, was more effective. This tendency
was well preserved in comparisons of variations 9, 10 and 11.
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1532 A. Tachibana et al. / FEBS Letters 586 (2012) 1529–1532regions at the terminals appear to be important for miRNA
binding. The signiﬁcance of double-stranded regions may also
be dependent on the direction, i.e. both terminals > 30 terminal >
50 terminal.
To test this, smaller variations (12–16) were designed as shown
in Fig. 2. These variations were constructed with one or two miRNA
binding site(s) and a double-stranded region. Variations 15 and 16
were constructed with the miRNA binding site and the double-
stranded region at 50 terminal and they were less effective than
variations 12, 13, and 14 with miRNA binding sites and double-
stranded regions at the 30 terminal.
A previous report shows that hairpin-structured DNA probes
bound anti-sense strands with higher afﬁnity than liner single-
stranded DNA probes [20]. In this study, we designed an experi-
ment to measure the afﬁnity of LidNA-type probe for miRNA
using Biacore 3000 (GE Healthcare). Three types of probe were
constructed and tested: LidNA-type probe with miRNA binding
site between two double-stranded regions (Fig. 3A), semi-
LidNA-type probe with miRNA binding site between a double-
stranded region and a single-stranded region (Fig. 3B), and
single-strand probe with miRNA binding site between two
single-stranded regions (Fig. 3C). Binding curves obtained showed
signiﬁcantly distinct dissociation constants, KD, for the three types
of probe. The KD of LidNA-type, semi-LidNA, and single-strand
probes were calculated to be 0.54 nM, 7.1 nM, and 1.0 lM,
respectively (Fig. 3D). The KD value (1.0 lM) on using the sin-
gle-strand probe was surprisingly higher than the concentration
(25 nM) on adding LidNA to cells as an miRNA inhibitor
(Fig. 1C). DNA has a very low afﬁnity for miRNA, therefore, any
DNA, except LidNA, remains to be used as an miRNA inhibitor.
If there is a double-stranded region in the vicinity to miRNA bind-
ing site like in the semi-LidNA-type probe, DNA binds to miRNA
with a high afﬁnity, and it may act as an miRNA inhibitor. The
KD value of LidNA-type probe (0.54 nM) suggests that DNA binds
to miRNA and acts as an miRNA inhibitor at the concentration of
10–25 nM. Comparison of the binding properties of LidNA with
LNA and 20-O-methylated RNA probes show that LidNA-type
probe has better afﬁnity than LNA and 20-O-methylated RNA
(Table S1). However, detailed binding properties of LidNA were
different from LNA and 20-O-methylated RNA. LidNA show higher
association rate constant, ka, than LNA and 20-O-methylated RNA,
but higher dissociation rate constant, kd (Table S1). The binding
mechanism of LidNA to miRNA is very interesting and under
investigation. The existence of double-stranded regions in the
vicinity enhances the binding ability of the miRNA binding site
for miRNA: this concept gave rise to generation of the ﬁrst miRNA
inhibitor constructed with unmodiﬁed DNA.
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